(Q35888211)

10 August 2017

Comorbidities, treatment and ensuing survival in men with prostate cancer (English)

1 reference

10 August 2017

1 reference

1 reference

Karim Chamie

1

1 reference

10 August 2017

Timothy J Daskivich

2

1 reference

10 August 2017

Lorna Kwan

3

1 reference

10 August 2017

Jessica Labo

4

1 reference

10 August 2017

Atreya Dash

5

1 reference

10 August 2017

Sheldon Greenfield

6

1 reference

10 August 2017

Mark S Litwin

7

1 reference

10 August 2017

21 September 2011

1 reference

Journal of General Internal Medicine

10 August 2017

1 reference

10 August 2017

27

1 reference

10 August 2017

5

1 reference

10 August 2017

492-499

1 reference

https://scigraph.springernature.com/pub.10.1007/s11606-011-1869-4

10 August 2017

0 references

cites work

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326114

Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1)

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326114

Is there an optimal comorbidity index for prostate cancer?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326114

Comorbidity and primary treatment for localized prostate cancer: data from CaPSURE

11 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326114

11 July 2018

https://api.crossref.org/works/10.1007%2FS11606-011-1869-4

Radical prostatectomy versus watchful waiting in early prostate cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326114

Temporal trends in radical prostatectomy complications from 1991 to 1998.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326114

Trends and black/white differences in treatment for nonmetastatic prostate cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326114

Factors that determine the treatment for local and regional prostate cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326114

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326114

Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.

11 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11606-011-1869-4

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11606-011-1869-4

Prostate cancer treatment for economically disadvantaged men: a comparison of county hospitals and private providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11606-011-1869-4

Initial treatment for prostate carcinoma in relation to comorbidity and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11606-011-1869-4

A Proportional Hazards Model for the Subdistribution of a Competing Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11606-011-1869-4

Factors Associated With Initial Therapy for Clinically Localized Prostate Cancer: Prostate Cancer Outcomes Study

21 January 2018

1 reference

12 December 2020

Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy

1 reference

12 December 2020

Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer

1 reference

12 December 2020

Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy

1 reference

12 December 2020

10.1007/S11606-011-1869-4

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

21935751

1 reference